Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Stem Cell-Based Therapy for Coronavirus Disease 2019.

Identifieur interne : 000211 ( 2020/Analysis ); précédent : 000210; suivant : 000212

Stem Cell-Based Therapy for Coronavirus Disease 2019.

Auteurs : Robert Chunhua Zhao [République populaire de Chine]

Source :

RBID : pubmed:32292113

Abstract

The novel coronavirus disease 2019 (COVID-19) has grown to be a global public-health emergency since patients were first detected in Wuhan, China, in December 2019. As of April 9, 2020, the novel coronavirus (named as SARS-CoV-2 by the International Committee on Taxonomy of Viruses on February 11) has infected 83,251 and 1,484,811 patients in China and the world, respectively. However, we have neither confirmed effective antiviral medications nor vaccines available to deal with this emergency. In this commentary, we offer an alternative promising therapy for COVID-19, that is, mesenchymal stem cell transplantation.

DOI: 10.1089/scd.2020.0071
PubMed: 32292113


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32292113

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Stem Cell-Based Therapy for Coronavirus Disease 2019.</title>
<author>
<name sortKey="Zhao, Robert Chunhua" sort="Zhao, Robert Chunhua" uniqKey="Zhao R" first="Robert Chunhua" last="Zhao">Robert Chunhua Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Cell Biology, School of Life Sciences, Shanghai University, Shanghai, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Cell Biology, School of Life Sciences, Shanghai University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32292113</idno>
<idno type="pmid">32292113</idno>
<idno type="doi">10.1089/scd.2020.0071</idno>
<idno type="wicri:Area/PubMed/Corpus">000139</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000139</idno>
<idno type="wicri:Area/PubMed/Curation">000139</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000139</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000176</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000176</idno>
<idno type="wicri:Area/Ncbi/Merge">003A49</idno>
<idno type="wicri:Area/Ncbi/Curation">003A49</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003A49</idno>
<idno type="wicri:Area/Main/Merge">000211</idno>
<idno type="wicri:Area/Main/Curation">000211</idno>
<idno type="wicri:Area/Main/Exploration">000211</idno>
<idno type="wicri:Area/2020/Extraction">000211</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Stem Cell-Based Therapy for Coronavirus Disease 2019.</title>
<author>
<name sortKey="Zhao, Robert Chunhua" sort="Zhao, Robert Chunhua" uniqKey="Zhao R" first="Robert Chunhua" last="Zhao">Robert Chunhua Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Cell Biology, School of Life Sciences, Shanghai University, Shanghai, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Cell Biology, School of Life Sciences, Shanghai University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Stem cells and development</title>
<idno type="eISSN">1557-8534</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The novel coronavirus disease 2019 (COVID-19) has grown to be a global public-health emergency since patients were first detected in Wuhan, China, in December 2019. As of April 9, 2020, the novel coronavirus (named as SARS-CoV-2 by the International Committee on Taxonomy of Viruses on February 11) has infected 83,251 and 1,484,811 patients in China and the world, respectively. However, we have neither confirmed effective antiviral medications nor vaccines available to deal with this emergency. In this commentary, we offer an alternative promising therapy for COVID-19, that is, mesenchymal stem cell transplantation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Zhao, Robert Chunhua" sort="Zhao, Robert Chunhua" uniqKey="Zhao R" first="Robert Chunhua" last="Zhao">Robert Chunhua Zhao</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000211 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000211 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:32292113
   |texte=   Stem Cell-Based Therapy for Coronavirus Disease 2019.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i   -Sk "pubmed:32292113" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021